128 related articles for article (PubMed ID: 37991412)
1. Population pharmacokinetics of mycophenolic acid and dose optimisation in adult Chinese kidney transplant recipients.
Rexiti K; Jiang X; Kong Y; Chen X; Liu H; Peng H; Wei X
Xenobiotica; 2023; 53(10-11):603-612. PubMed ID: 37991412
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
van Hest RM; van Gelder T; Vulto AG; Mathot RA
Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
[TBL] [Abstract][Full Text] [Related]
3. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.
Yu ZC; Zhou PJ; Wang XH; Françoise B; Xu D; Zhang WX; Chen B
Acta Pharmacol Sin; 2017 Nov; 38(11):1566-1579. PubMed ID: 28836585
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated with tacrolimus: A population analysis.
Yang CL; Sheng CC; Liao GY; Su Y; Feng LJ; Xia Q; Jiao Z; Xu DJ
J Clin Pharm Ther; 2021 Dec; 46(6):1564-1575. PubMed ID: 34312870
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Exposure in Chinese Renal Allograft Recipients After Administration of EC-MPS.
Chen B; Shao K; An HM; Shi HQ; Lu JQ; Zhai XH; Liu XX; Wang XH; Xu D; Zhou PJ
J Clin Pharmacol; 2019 Apr; 59(4):578-589. PubMed ID: 30537048
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
de Winter BC; van Gelder T; Glander P; Cattaneo D; Tedesco-Silva H; Neumann I; Hilbrands L; van Hest RM; Pescovitz MD; Budde K; Mathot RA
Clin Pharmacokinet; 2008; 47(12):827-38. PubMed ID: 19026038
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen.
Reséndiz-Galván JE; Romano-Aguilar M; Medellín-Garibay SE; Milán-Segovia RDC; Niño-Moreno PDC; Jung-Cook H; Chevaile-Ramos JA; Romano-Moreno S
Eur J Pharm Sci; 2020 Jul; 150():105370. PubMed ID: 32387086
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of mycophenolate mofetil.
Bullingham RE; Nicholls AJ; Kamm BR
Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
[TBL] [Abstract][Full Text] [Related]
10. Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling.
Rong Y; Wichart J; Hamiwka L; Kiang TKL
Clin Pharmacokinet; 2023 Sep; 62(9):1289-1303. PubMed ID: 37493886
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study.
Riglet F; Bertrand J; Barrail-Tran A; Verstuyft C; Michelon H; Benech H; Durrbach A; Furlan V; Barau C
Drugs R D; 2020 Dec; 20(4):331-342. PubMed ID: 33025511
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.
Barau C; Furlan V; Debray D; Taburet AM; Barrail-Tran A
Br J Clin Pharmacol; 2012 Sep; 74(3):515-24. PubMed ID: 22329639
[TBL] [Abstract][Full Text] [Related]
13. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
15. Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies.
Wang X; Wu Y; Huang J; Shan S; Mai M; Zhu J; Yang M; Shang D; Wu Z; Lan J; Zhong S; Wu M
Front Pharmacol; 2021; 12():748609. PubMed ID: 34867352
[No Abstract] [Full Text] [Related]
16. Population Pharmacokinetics of Mycophenolic Acid Co-Administered with Tacrolimus in Corticosteroid-Free Adult Kidney Transplant Patients.
Rong Y; Mayo P; Ensom MHH; Kiang TKL
Clin Pharmacokinet; 2019 Nov; 58(11):1483-1495. PubMed ID: 31055791
[TBL] [Abstract][Full Text] [Related]
17. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.
de Winter BC; Mathot RA; Sombogaard F; Neumann I; van Hest RM; Doorduijn JK; van Gelder T
Ther Drug Monit; 2010 Oct; 32(5):606-14. PubMed ID: 20720518
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients.
Rong Y; Mayo P; Ensom MHH; Kiang TKL
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):409-422. PubMed ID: 30377942
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation.
Staatz CE; Duffull SB; Kiberd B; Fraser AD; Tett SE
Eur J Clin Pharmacol; 2005 Aug; 61(7):507-16. PubMed ID: 16049701
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent clearance of mycophenolic acid in renal transplant recipients.
van Hest RM; van Gelder T; Bouw R; Goggin T; Gordon R; Mamelok RD; Mathot RA
Br J Clin Pharmacol; 2007 Jun; 63(6):741-52. PubMed ID: 17214827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
